Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.34 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3185741 | 1.00 | HTT (0.34) | HTTKDM4EALDH1A1NCOA1NCOA3 | |
| SCHEMBL4063475 | 0.83 | SSTR4 (0.38) | KDM4EPOLBGAA | |
| SCHEMBL4063473 | 0.83 | SSTR4 (0.38) | KDM4EPOLBGAA | |
| SCHEMBL4066138 | 0.82 | — | — | |
| SCHEMBL4066135 | 0.82 | — | — | |
| SCHEMBL4067977 | 0.80 | HSD17B10 (0.33) | KDM4EALDH1A1HPGD | |
| SCHEMBL4067972 | 0.80 | HSD17B10 (0.33) | KDM4EALDH1A1HPGD | |
| SCHEMBL4066131 | 0.80 | CYP1A2 (0.39) | CYP2C19 | |
| SCHEMBL4066126 | 0.80 | CYP1A2 (0.39) | CYP2C19 | |
| SCHEMBL4071056 | 0.78 | KDM4E (0.36) | HTTKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7652032-B2 | 5-Thioxylopyranose compounds | LABORATOIRES FOURNIER S.A. (FR) | 2010-01-26 | — | — | US | disclosed |
| EP-2041153-B1 | NEW 5-THIOXYLOPYRANOSE DERIVATIVES | FOURNIER LAB SA (FR) | 2009-10-21 | — | — | EP | disclosed |
| US-20090118325-A1 | 5-Thioxylopyranose Compounds | LABORATOIRES FOURNIER S.A. (FR) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118325-A1 | 5-Thioxylopyranose Compounds | STS, F2, CBR1 | HTT 3798/4885KDM4E 2404/4885ALDH1A1 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.